CUYRF(CUYRF)
CUYRF
No analyst ratings available
No analyst price targets available for CUYRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $103.27B | $112.51B | $128.19B | $148.93B | $166.54B |
| Low | $101.34B | $107.60B | $124.13B | $144.21B | $161.26B |
| High | $106.94B | $117.12B | $133.11B | $154.64B | $172.92B |
| EBITDA Avg | $33.31B | $36.29B | $41.35B | $48.04B | $53.72B |
| Low | $32.69B | $34.71B | $40.04B | $46.52B | $52.02B |
| High | $34.49B | $37.78B | $42.94B | $49.88B | $55.78B |
| EBIT Avg | $30.45B | $33.17B | $37.80B | $43.91B | $49.11B |
| Low | $29.88B | $31.73B | $36.60B | $42.52B | $47.55B |
| High | $31.53B | $34.53B | $39.25B | $45.60B | $50.99B |
| Net Income Avg | $17.08B | $19.90B | $23.03B | — | — |
| Low | $16.38B | $19.08B | $22.08B | — | — |
| High | $17.93B | $20.89B | $24.18B | — | — |
| EPS Avg | $1058.93 | $1233.63 | $1427.48 | — | — |
| Low | $1015.31 | $1182.81 | $1368.68 | — | — |
| High | $1111.73 | $1295.14 | $1498.66 | — | — |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 2 / — | 1 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $25.62B | $26.52B | $27.39B |
| Low | $24.90B | $25.97B | $26.72B |
| High | $26.48B | $27.50B | $28.36B |
| EBITDA Avg | $8.26B | $8.55B | $8.84B |
| Low | $8.03B | $8.38B | $8.62B |
| High | $8.54B | $8.87B | $9.15B |
| EBIT Avg | $7.55B | $7.82B | $8.08B |
| Low | $7.34B | $7.66B | $7.88B |
| High | $7.81B | $8.11B | $8.36B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 3 / — | 1 / — |